fig8

Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma

Figure 8. Immune Characteristics of MOMLS. (A) TMB distribution in those with high and low MOMLS scores; (B) TNB in those with high and low MOMLS scores; (C) Differences in M1 macrophage levels between the high and low MOMLS score groups; (D) Scatter plot illustrating the relationship between MOMLS and M1 macrophage levels. MOMLS: Multi-omics-driven machine learning signature; TMB: tumor mutational burden; TNB: tumor neoantigen burden.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/